Liver Flashcards

1
Q

Features hepatic dysfunction

A
Encephalopathy
Jaundice
Epistaxis
Cholestasis (pale stools, dark urine, deficiency fat soluble vit)
Ascites
Hypotonia
Peripheral neuropathy
Rickets (Vit D deficiency)
Varices with portal hypertension
Spider Naevi
Muscle wasting (malnutrition)
Bruising and petechia
Splenomegaly with portal hypertension
Hepatorenal failure
Palmar erythema
Clubbing
Loss of fat stores (malnutrition)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Physiological jaundice

A

Common
90% resolve by 2 w
- 3w if preterm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Feature Bile Duct Atresia

A
Prolonged neonatal jaundice
Progressive fibrosis and obliteration of the biliary tree
Chronic liver failure and death within 2y
Mild Jaundice
Pale stools
Faltering growth
Hepatomegaly
Splenomegaly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ix Biliary atresia

A

Raised conjugated bilirubin
Abnormal LFTs
Fasting abdo US: contracted or absent gall bladder
Dx by ERCP: failure to outline normal biliary tree
Liver biopsy: neonatal hepatitis w extrahepatic biliary obstructive features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mx Biliary Atresia

A

Palliative surgery:
-Kasai hepatoportoenterostomy (jejenum anastamoses with porta hepatis)
-fibrotic ducts bypassed to allow biliary drainage
Early surgery increases success rate
Fat soluble vitamin supplementation
Liver transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cx Biliary Atresia

A

Cholangitis
Cirrhosis
Malnutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Causes of prolonged neonatal jaundice

A
Breast milk jaundice
Infection (esp UTI)
Haemolytic anaemia
Hypothyroidism
High GI obstruction
Critter-Najjar syndrome
Biliary Atresia
Choledochal cysts
Neonatal hepatitis syndrome
Intrahepatic biliary hypoplasia (alagille syndrome)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of neonatal hepatitis syndrome

A
Congenital infection
Inborn errors of metabolism
alpha1-Antitripsin deficiency
Galactosaemia
Tryosinaemia type 1
Errors of bile acid synthesis
Progressive familial intrahepatic cholestasis
Cystic fibrosis
Intestinal failure associated liver disease (parental nutrition)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Features Alagille syndrome

A

AD inheritance
Characteristic triangular face
Skeletal abnormality .e.g. Butterfly vertebrae
Congenital heart disease: peripheral pulmonary stenosis
Renal tubular disorders
Eye defects
Profoundly choleostatic with pruritis and faltering growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mx Alagille Syndrome

A
Confirmed by genetic test
Nutrition and fat soluble vitamins
Pruritis difficult to manage
Liver transplant
Death by cardiac cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Features Progressive familial intrahepatic cholestasis

A
AR disorder affecting bile salt transport
Jaundice
Intense pruritis
Faltering growth
Rickets
Diarrhoea
Hearing loss
Gallstones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mx Progressive familial intrahepatic cholestasis

A

Dx by gene mutation in bile salt transporter genes
Nutritional support and fat soluble vitamins
Liver transplant due to progression of fibrosis
Pruritis difficult to manage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Features alpha1-Antitypsin deficiency

A

AR disorder (protease inhibitor PiZZ chromosome 14)
Protein accumulation within hepatocytes
Liver disease in infants and children
Lung disease in adulthood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Presentation alpha1-Antitrypsin deficiency

A
Prolonged neonatal jaundice
Bleeding due to Vit K defieincy
Hepatomegaly
Splenomegaly
Cirrhosis
Portal hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mx alpha1-Antitrypsin Deifiency

A

Dx on enzyme level in plasma and protein phenotype
50% have good prognosis
Liver transplant
Avoid smoking: risk of pulmonary disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Features Galactosaeia

A
Rare
Poor feeding
Vomiting
Jaundice
Hepatomegaly 
Symptomatic when fed milk
Untreated leads to cataracts and developmental delay
Late features: ovarian failure, learning difficulty
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Galactosaemia fatal course

A

Usually caused by Gram negative sepsis
Shock
Haemorrhage
DIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ix Galactosaemia

A

Detecting galactose in urine
Enzyme galactose-1-phosphate-uridyl transferase in rbc
Can be masked by recent blood transfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Mx Galactosaemia

A

Galactose free diet prevent liver disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Features Fulimant Hepatitis

A
Development of hepatic necrosis with subsequent loss of liver function
\+/- liver encephalopathy
Due to infection or metabolic conditions
Jaundice
Coagulopathy
Hypoglycaemia
Electrolyte disturbance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Early signs hepatic encephalopathy

A

Alternate periods of irritability and confusion with drowsiness
Aggressive and difficult behaviour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cx fulminant hepatitis

A

Cerebral oedema
Haemorrhage
Sepsis
Pancreatisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Dx fulminant hepatitis

A
Bilirubin normal in early stages
Transaminases elevated 10-100x normal level
Alkaline phosphatase increased
Abnormal coagulation
Plasma ammonia increased
EEG shows hepatic encephalopathy 
CT cerebral oedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Mx fulminant hepatitis

A

Maintain blood glucose >4mmol/L: IV dextrose
Broad spectrum Abx : sepsis prevention
Antifungals
IV vitamin K
H2 blocking/PPIs: prevent GI haemorrhage
Fluid restriction and mannitol in cerebral oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Poor prognostic factors fulminant hepatitis

A
Shrinking liver
Rising bilirubin
Falling transaminases
Worsening coagulopathy 
Progression to coma
-Without liver transplant ~ 70% in coma will die
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Causes of acute liver failure <2y

A
Infection .e.g. Herpes simplex
Metabolic disease
Seronegative hepatitis
Drug induced
Neonatal haemochromatosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Causes liver failure >2y

A
Seronegative hepatitis
Paracetamol OD
Mitochondrial disease
Wilson disease
Autoimmune hepatitis
28
Q

Causes chronic liver disease

A
Post viral hepatitis B/C
Autoimmune hepatitis
Sclerosing cholangitis
Drug induced liver disease
Cystic fibrosis
Wilson disease
Fibropolycystic liver disease
Non-alcoholic fatty liver disease
Alpha1-antitrypsin deficiency
29
Q

Features Viral hepatitis

A
Nausea 
Vomiting
Abdominal pain
Lethargy
Jaundice 
Large tender liver
Splenomegaly
Raised transaminases
Normal coagulation
30
Q

Features Hepatitis A

A

Mild illness 2-4w

Self limiting prolonged cholestatic hepatitis and fuliminant hepatitis

31
Q

Mx Hepatitis A

A

IgM antibody Dx
No treatment
Vaccination of close contacts within 2w of onset
Human normal immunoglobulin in those at high risk

32
Q

Transmission of hepatitis B

A

Perinatal from mother to baby
Horizontal spread within families
Inoculation with infected blood via needles, dialysis etc.
Sexual transmission

33
Q

Outcome for infants with HBV

A

Usually asymptomatic

90% become chronic carriers

34
Q

Outcomes for older children with HBV

A

Usually asymptomatic
Majority resolve spontaneously
1-2% develop acute liver failure
5-10% chronic carriers

35
Q

Dx Hepatitis B

A

HBV antigens and antibodies
IgM core antibodies in acute infection
HBV surface antigen ongoing infectivity

36
Q

Cx chronic hepatitis

A

Cirrhosis

Hepatocellular carcinoma

37
Q

Mx chronic HBV

A

Poor efficacy
Interferon or Pegylated interferon successful in 30-50%
Antiviral .e.g. Lamivudine, adefovir effective in 25%

38
Q

Prevention hepatitis B

A

Antenatal maternal screening
Surface antigen positive: babes receive vaccination from birth
E Antigen positive: hepatitis B immunoglobulin
Check antibody response to vaccination at 12m
-further vaccination required in 5%
Rest of family vaccinated

39
Q

Features Hepatitis C

A

IVDU
Vertical transmission greater in HIV co-infection
Majority become chronic carriers: cirrhosis and hepatocellular carcinoma risk

40
Q

Mx hepatitis C

A

Pegylated interferon and ribavirin is curative

Treatment >3y old: may resolve with viral infections

41
Q

Features hepatitis D

A

Cannot replicate without HBV
Causes acute exacerbation of chronic HBV
Cirrhosis in chronic infection

42
Q

Features Hepatitis E

A

Mild self limiting illness in most
Associated with water, infected pork, blood transfusion
During pregnancy: fulminant hepatic failure with high mortality

43
Q

Features autoimmune hepatitis and sclerosing cholangitis

A

Presents 7-10y
More common in girls
Acute hepatitis, fulminant hepatitis, or chronic liver disease
Autoimmune features: skin rash, arthritis, haemolytic anaemia, nephritis
Association with IBD, coeliac, other autoimmune disease

44
Q

Dx Autoimmune hepatitis and sclerosing cholangitis

A
Elevated total protein
Hyperglammaglobulinaemia IgG >20g/L
Positive autoantibodies
Low serum complement C4
Typical histology
45
Q

Mx Autoimmune hepatitis and sclerosing cholangitis

A

Prednisone
Azathioprine
Urosodeoxycholic acid- sclerosing cholangitis

46
Q

Liver disease in CF

A

Second most common cause of death
Most common abnormality steatosis
Other cx; progressive biliary fibrosis from thick tenacious bile, cirrhosis, portal hypertension
Histology: fatty liver, focal biliary fibrosis, focal modular cirrhosis

47
Q

Mx Liver disease in CF

A
Supportive therapy
Endoscopic treatement of varices
Nutritional therapy
Ursodeoxycholic acid
Liver transplantation/ heart-lung transplantation
48
Q

Features Wilson disease

A

AR mutation in caeruloplasmin
Defective excretion of copper in the bile
Accumulation of copper in brain, liver, kidney, cornea
Presents >3y

49
Q

Presentation Wilson disease

A
Young children: liver disease
Older children: neuropsychiatric disease (extrapyrimidal signs)
Renal tubular dysfunction
Vitamin D resistant rickets
Haemolytic anaemia
Kayser-fleischer rings develop >7y
50
Q

Ix Wilson disease

A

Low serum caeruloplasmin and copper
Increased urinary copper excretion
-further increased by cheating agent penicillamie
Dx hepatic copper on biopsy or gene mutation

51
Q

Mx Wilson disease

A
Penicillamine or trientine
-promote urinary copper excretion
-reduce hepatic and CNS copper
Zinc: reduces copper absorption 
Pyridoxine: to prevent peripheral neuropathy
52
Q

Features Fibroplastic Liver Disease

A

Inherited condition affecting biliary tree development
Liver cystic disease
Fibrosis
Renal disease

53
Q

Features congenital hepatic fibrosis

A
Children >2y
Hepatosplenomegaly
Abdominal distension
Portal hypertension
Normal LFTs
Coexisting cystic renal disease: hypertension and renal dysfunction
Histology: bands of hepatic fibrosis
54
Q

Cx congenital hepatic fibrosis

A

Portal hypertension
Varices
Cholangitis

55
Q

Features non-alcoholic fatty liver disease

A

Fatty deposits and inflammation, fibrosis, cirrhosis and liver failure
Associated with metabolic syndrome and obesity
Usually asymptomatic
RUQ pain, lethargy

56
Q

Ix Non-alcoholic fatty liver disease

A

Echogenic liver on US
Mildly elevated transaminases
Biopsy: marked steatosis +/- inflammation and fibrosis

57
Q

Cx chronic liver disease

A
Nutrition: fat malabsorption (long chain), protein malnutrition (high liver catabolism), anorexia (NG feed)
Fat soluble vitamin (oral or IM)
Pruritus
Encephalopathy
Cirrhosis
Portal hypertension
Oesophageal varices
Ascites
Spontaneous bacterial peritonitis
Renal failure
58
Q

Indications for liver transplant

A

Severe malnutrition unresponsive to therapy
Cx refractory management: bleeding, varices, ascites
Poor quality of life
Failure of growth and development

59
Q

Post transplanation Cx Liver

A
Primary non function
Hepatic artery thrombosis
Biliary leaks and strictures
Rejection
Sepsis
Death occurs within first 3m
1y survival ~ 90%
20y survival >80%
60
Q

Mx Pruritis in liver disease

A
Loose cotton clothing
Avoid overheating
Cut nails
Emollients
Phenobarbital: stimulate bile flow
Cholestyramine: absorb bile salts
Ursodeoxycholic acid: solubise bile
Rifampicin: enzyme inducer
61
Q

Fat soluble vitamins defiencies

A

K: bleeding
A: retinal changes and night blindness
E: peripheral neuropathy, haemolysis, ataxia
D: Rickets and fractures

62
Q

Features Cirrhosis

A

Extensive fibrosis with regenerative nodules
2’ to hepatocellular disease/chronic bile duct obstruction
Diminished hepatic function
Portal hypertension
Splenomegaly, varices, ascites
Risk of hepatocellular carcinoma

63
Q

Signs of cirrhosis

A
Jaundice
Palmar erythema
Plantar erythema
Telangiectasia
Spider navaei
Malnutrition
Hypotonia
Dilated abdominal veins
Splenomegaly
Shrunken and impalpable liver
64
Q

Screening in cirrhosis

A

Cause of chronic liver disease
Upper GI endoscopy: varices and erosive gastritis
Abdominal US: liver, spleen, varices
Biopsy

65
Q

Ix decompensated cirrhosis

A

Elevated aminotransferases and alkaline phosphatase
Decreased plasma albumin
Prolonged PT

66
Q

Mx oesophageal varices

A

Upper GI endoscopy
Blood transfusion and H2 antagonist in acute bleeds
Octreotide infusion, vasopressin analogues, endoscopic band ligation and sclerotherapy in persistent bleeds
Portocaval shunting
Stent placement between hepatic and portal vein